Experiment 394723
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | STOCKSMEIER,U: EBERLIEIN,M:. (1992). DEPRESSIVE MOOD IN CEREBRAL DYSFUNCTION, THE EFFECTS OF A GINKGO BILOBA EXTRACT TESTED IN A DOUBLE-BLIND STUDY.. 6() |
| Amount utilized | |
| Compound isolated | |
| Disease | A CLINCIAL TRIAL OF THE INFLUENCE OF GINKGO BILOBA EXTRACT EGB 761 ON THE DEPRESSIVE MOOD OF PATIENTS WITH CEREBRAL DISTURBANCES. PATIENTS WITH CLINICAL CEREBRAL DISTURBANCES REPORTING A DEPRESSIVE MOOD AS SYMPTOM WERE TREATED WITHIN THE FRAMEWORK OF A PLACEBO-CONTROLLED, RANDOMISED DOUBLE-BLIND STUDY OVER A PERIOD OF 12 WEEKS RECEIVING 40 MG EGB 761 OR, AS ALTERNATIVE, PLACEBO T.I.D. THE DEPRESSIVE SYMPTOMS WERE RECORDED USING THE HAMILTON DEPRESSION SCALE (HAMD). MEASURED BY COMPARISON WITH THE TARGET CHARACTERISTIC OF THE INVESTIGATION, THE SUM SCORE OF TIEM 1 THROUGH 17 OF THE HAMD, DEPRESSIVE SYMPTOMS WERE REDUCED TO A FAR GREATER EXTENT BY ACTIVE MEDICATION THAN THROUGH PLACEBO. WHEREAS THE DIFFERENCE BETWEEN THE BEGINNING OF THE STUDY, THESE GROUPS SHOWED A SIGNIFICANT DIFFERENCE BY ITS END. IT WAS ALSO ONCE MORE POSSIBLE TO CONFIRM THE SAFETY OF THE DRUG TESTED IN APPLICATION. |
| Dose amount | 120.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | ETOH(100%)EXT |
| Gender | GIVEN TO BOTH SEXES |